At a glance
- Originator Pfizer
- Class Antibacterials
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 20 Oct 1998 Discontinued-Preclinical for Bacterial infections in USA (Unknown route)